NASDAQ
Artiva Biotherapeutics, Inc. (ARTV)
♥ 587 Thanks from members
Artiva Biotherapeutics (ARTV) exhibits positive web sentiment driven by promising EULAR 2026 clinical data and FDA RMAT designation for AlloNK in rheumatoid arthritis, though counterbalanced by valuation concerns and past capital dilution.